Free oral cancer screenings offered at Midwinter Meeting
DentalEZ Group is teaming up with Henry Schein and the Oral Cancer Foundation to provide free oral cancer screenings at this year’s Chicago Midwinter Dental
DentalEZ Group is teaming up with Henry Schein and the Oral Cancer Foundation to provide free oral cancer screenings at this year’s Chicago Midwinter Dental
TORONTO – An analysis of data from a recent Canadian health survey did not reveal a significant association between obesity and periodontitis — despite the
While cancer survival rates are improving, common cancer therapies such as chemoradiation often cause acute oral complications and toxicities that are largely unavoidable, according to
The February Journal of the California Dental Association explores salivary diagnostics, taking a significant posture in dentistry based on its recent advancements in the basic,
Computed tomography (CT) texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research presented
A Maine dentist has been ordered to pay $72,000 to two former dental hygienists who complained about the office’s infection control procedures. The U.S. Department
Obesity, which impacts roughly one-third of the U.S. population, has been linked to periodontal disease, according to an article published in the January/February 2013 issue
Soligenix, a development-stage biopharmaceutical company, has formed a medical advisory board to provide medical/clinical strategic guidance to the company as it advances the development of
DentalEZ Group has unveiled the next-generation version of the Identafi oral cancer screening device from its StarDental division. Now available, the new version features a
Researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) have developed an imaging system enclosed in a capsule about the size of
Marijuana has long been used to help cancer patients better tolerate the side effects of chemotherapy. Now new research at the New York University College
Although a large majority of head and neck cancers (HNC) have a deregulation of the PI3K/AKT/mTOR pathway, deregulation of this pathway does not necessarily signify